QQQS
QQQS
About Invesco NASDAQ Future Gen 200 ETF
The Invesco NASDAQ Future Gen 200 ETF (the Fund) aims to provide exposure to the Nasdaq Innovators Completion Cap Index (the Index). To achieve this, the Fund allocates at least 90% of its total assets to the securities that comprise the Index. The Index itself is composed of 200 small-capitalization companies, which Nasdaq selects based on the relative value of their patent portfolios compared...
About Invesco NASDAQ Future Gen 200 ETF
The Invesco NASDAQ Future Gen 200 ETF (the Fund) aims to provide exposure to the Nasdaq Innovators Completion Cap Index (the Index). To achieve this, the Fund allocates at least 90% of its total assets to the securities that comprise the Index. The Index itself is composed of 200 small-capitalization companies, which Nasdaq selects based on the relative value of their patent portfolios compared...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 QTTB | Q32 Bio Inc. | 0.97% | 9.92K | $212.09K |
 AGEN | Agenus Inc. | 0.88% | 31.32K | $191.69K |
 NWL | Newell Brands Inc. | 0.76% | 32.24K | $165.73K |
 MYGN | Myriad Genetics, Inc. | 0.74% | 27.61K | $161.82K |
 TXG | 10x Genomics, Inc. | 0.74% | 3.87K | $161.73K |
 RPD | Rapid7, Inc. | 0.72% | 13.08K | $155.95K |
 AGIO | Agios Pharmaceuticals, Inc. | 0.69% | 3.73K | $151.25K |
 QDEL | QuidelOrtho Corporation | 0.69% | 8.42K | $150.62K |
 RIGL | Rigel Pharmaceuticals, Inc. | 0.68% | 3.60K | $148.51K |
 AKBA | Akebia Therapeutics, Inc. | 0.68% | 107.48K | $148.32K |
 LGND | Ligand Pharmaceuticals Incorporated | 0.67% | 472 | $145.97K |
 PSNL | Personalis, Inc. | 0.66% | 9.62K | $144.62K |
 CLPT | ClearPoint Neuro, Inc. | 0.66% | 8.65K | $142.84K |
 OFIX | Orthofix Medical Inc. | 0.64% | 11.83K | $139.44K |
 QTRX | Quanterix Corporation | 0.64% | 35.83K | $139.01K |
 SIBN | SI-BONE, Inc. | 0.64% | 7.77K | $138.76K |
 MLKN | MillerKnoll, Inc. | 0.63% | 6.78K | $137.37K |
 XNCR | Xencor, Inc. | 0.63% | 9.23K | $138.06K |
 ATRC | AtriCure, Inc. | 0.63% | 3.96K | $137.88K |
 ATEC | Alphatec Holdings, Inc. | 0.63% | 14.15K | $137.78K |
SECTOR HOLDINGS
Healthcare
Technology
Cash & Others
Industrials
Consumer Cyclical
Communication Services
Energy
Consumer Defensive
Basic MaterialsASSET ALLOCATION BY REGION
United States
Canada
Israel
United Kingdom
China
Taiwan
Hong Kong
Belgium
Singapore
Australia
Bermuda
Spain
Ireland
Sweden
GermanySECTOR HOLDINGS
Healthcare Technology Cash & Others Industrials Consumer Cyclical Communication Services Energy Consumer Defensive Basic MaterialsASSET ALLOCATION BY REGION
United States Canada Israel United Kingdom China Taiwan Hong Kong Belgium Singapore Australia Bermuda Spain Ireland Sweden GermanyHoldings (Top 20)
QTTB
Q32 Bio Inc.
AGEN
Agenus Inc.
NWL
Newell Brands Inc.
MYGN
Myriad Genetics, Inc.
TXG
10x Genomics, Inc.
RPD
Rapid7, Inc.
AGIO
Agios Pharmaceuticals, Inc.
QDEL
QuidelOrtho Corporation
RIGL
Rigel Pharmaceuticals, Inc.
AKBA
Akebia Therapeutics, Inc.
LGND
Ligand Pharmaceuticals Incorporated
PSNL
Personalis, Inc.
CLPT
ClearPoint Neuro, Inc.
OFIX
Orthofix Medical Inc.
QTRX
Quanterix Corporation
SIBN
SI-BONE, Inc.
MLKN
MillerKnoll, Inc.
XNCR
Xencor, Inc.
ATRC
AtriCure, Inc.
ATEC
Alphatec Holdings, Inc.